These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 9636499)
1. Preoperative induction with tacrolimus does not have a detrimental effect on primary graft function in adult cadaveric renal transplantation. Morris-Stiff G; Singh J; Balaji V; Ostrowski K; Webley Y; Moore R; Lord R; Jurewicz WA Transplant Proc; 1998 Jun; 30(4):1230-1. PubMed ID: 9636499 [No Abstract] [Full Text] [Related]
2. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression. Toda F; Tanabe K; Tokumoto T; Ishikawa N; Koga S; Ito S; Yagisawa T; Toma H Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909 [No Abstract] [Full Text] [Related]
3. Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study. Wong KM; Cheung CY; Chan YH; Chak WL; Choi KS; Chau KF; Li CS Transplant Proc; 2000 Nov; 32(7):1721-2. PubMed ID: 11119907 [No Abstract] [Full Text] [Related]
4. Oral vs intravenous tacrolimus-based induction therapy in renal transplantation. Tojimbara T; Kimikawa M; Nakajima I; Sato S; Nakamura M; Ishida H; Tanabe K; Koyama I; Utsumi K; Sannomiya A; Tsuji K; Fuchinoue S; Agishi T Transplant Proc; 1999 Nov; 31(7):2763-4. PubMed ID: 10578282 [No Abstract] [Full Text] [Related]
5. Primary tacrolimus-based immunosuppression in renal allograft recipients: a single center experience. Lye WC Transplant Proc; 2000 Nov; 32(7):1700-1. PubMed ID: 11119898 [No Abstract] [Full Text] [Related]
10. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience. Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911 [No Abstract] [Full Text] [Related]
11. Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group. Forsythe J Transplant Proc; 1999 Nov; 31(7A):69S-71S. PubMed ID: 10576049 [No Abstract] [Full Text] [Related]
12. The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60. Xenos EX; Ciancio G; Burke GW; Roth D; Miller J Clin Transplant; 1997 Oct; 11(5 Pt 2):497-9. PubMed ID: 9361949 [TBL] [Abstract][Full Text] [Related]
13. Immunosuppression in cadaveric renal transplant recipients from non-heart-beating donors in a single center. Ushigome H; Okamoto M; Kadotani Y; Nakamura K; Akioka K; Ohmori Y; Yoshimura N Transplant Proc; 2002 Aug; 34(5):1681-2. PubMed ID: 12176533 [No Abstract] [Full Text] [Related]
14. The long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart beating donors. Fukuhara N; Ono Y; Hattori R; Nishiyama N; Yamada S; Kamihira O; Kinukawa T; Ohshima S Clin Transplant; 2005 Apr; 19(2):153-7. PubMed ID: 15740548 [TBL] [Abstract][Full Text] [Related]
15. Long-term results of living kidney transplantation under tacrolimus immunosuppression: a single-center experience. Tanabe K; Ishikawa N; Tokumoto T; Takahashi K; Kanematsu A; Kitani R; Fuchinoue S; Oshima T; Yagisawa T; Toma H Transplant Proc; 1998 Jun; 30(4):1224-6. PubMed ID: 9636497 [No Abstract] [Full Text] [Related]
16. Prospective randomized study comparing FK 506 (Prograft) and cyclosporine A (Neoral) as primary immunosuppression in cadaveric renal transplants at a single institution: interim report of the first 80 cases. Morris-Stiff G; Singh J; Ostrowski K; Balaji V; Moore R; Darby C; Lord R; Jurewicz WA Transplant Proc; 1998 Jun; 30(4):1295-6. PubMed ID: 9636525 [No Abstract] [Full Text] [Related]
17. Conversion from cyclosporine to tacrolimus in renal allograft recipients with delayed graft function from severe acute tubular necrosis. Jang HJ; Kim SC; Han DJ Transplant Proc; 2000 Nov; 32(7):1714-5. PubMed ID: 11119904 [No Abstract] [Full Text] [Related]
18. Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation. Yu L; Wang Y; Fu SJ; Cheng XJ Transplant Proc; 2000 Nov; 32(7):1709-10. PubMed ID: 11119902 [No Abstract] [Full Text] [Related]
19. Delayed tacrolimus is safe with basiliximab induction therapy. Lee KH; Da Costa M; Lim SG; Tan KC Liver Transpl; 2002 Aug; 8(8):732. PubMed ID: 12149770 [No Abstract] [Full Text] [Related]
20. Quadruple immunotherapy will promise excellent graft survival in cadaveric renal transplants using cardiac arrest donor grafts. Hoshinaga K; Shiroki R; Higuchi T; Horiba Y; Yanaoka M; Naide Y Transplant Proc; 1996 Jun; 28(3):1591-3. PubMed ID: 8658798 [No Abstract] [Full Text] [Related] [Next] [New Search]